|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/198 | |
| A61K 31/351 | |||
| A61K 31/403 | |||
| A61K 31/4439 | |||
| A61K 31/4985 | |||
| A61K 31/64 | |||
| A61K 9/20 | |||
| A61K 9/28 | |||
| A61K 31/155 | |||
| A61K 9/24 |
| (11) | Number of the document | 2670397 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12704975.7 |
| Date of filing the European patent application | 2012-01-31 | |
| (97) | Date of publication of the European application | 2013-12-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/023262 |
| Date | 2012-01-31 |
| (87) | Number | WO 2012/106303 |
| Date | 2012-08-09 |
| (30) | Number | Date | Country code |
| 201161438307 P | 2011-02-01 | US |
| (72) |
NARANG, Ajit, US
RAO, Venkatramana, M., US
DESAI, Divyakant, S., US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
AstraZeneca UK Limited, 15 Stanhope Gate, London W1K 1LN, GB |
| (54) | PHARMACEUTICAL FORMULATIONS INCLUDING AN AMINE COMPOUND |
| PHARMACEUTICAL FORMULATIONS INCLUDING AN AMINE COMPOUND |